PTTG induces EMT through integrin α v Β 3-focal adhesion kinase signaling in lung cancer cells

Oncogene

Volumn 31, Issue 26, 2012, Pages 3124-3135

  Shah, P P ^a   Fong, M Y ^b   Kakar, S S ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

lung cancer; PTTG; securin

Indexed keywords

ADENOVIRUS VECTOR; CELL ADHESION MOLECULE; DOCKING PROTEIN; FOCAL ADHESION KINASE; METAVINCULLIN; PAXILLIN; PROTEIN CDC42; PROTEIN DOCK 180; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; TALIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; VITRONECTIN RECEPTOR;

ARTICLE; CANCER CELL; CELL MIGRATION; CELL MOTILITY; CYTOSKELETON; DOWN REGULATION; DOWNSTREAM PROCESSING; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; LUNG CANCER; ONCOGENE; PITUITARY TUMOR TRANSFORMING GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ACTIN CYTOSKELETON; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTEGRIN ALPHAVBETA3; LUNG NEOPLASMS; NEOPLASM PROTEINS; OLIGOPEPTIDES; PHOSPHORYLATION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

ADENOVIRIDAE;

EID: 84863184549     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.488     Document Type: Article

References (82)

1. Agiostratidou G, Hulit J, Phillips GR, Hazan RB. (2007). Differential cadherin expression: potential markers for epithelial to mesenchymal transformation during tumor progression. J Mammary Gland Biol Neoplasia 12: 127-133. (Pubitemid 47215430)
2. Altun-Gultekin ZF, Chandriani S, Bougeret C, Ishizaki T, Narumiya S, de Graaf P et al. (1998). Activation of Rho-dependent cell spreading and focal adhesion biogenesis by the v-Crk adaptor protein. Mol Cell Biol 18: 3044-3058. (Pubitemid 28183473)
3. Arold ST, Hoellerer MK, Noble ME. (2002). The structural basis of localization and signaling by the focal adhesion targeting domain. Structure 10: 319-327. (Pubitemid 34230620)
4. Becam IE, Tanentzapf G, Lepesant JA, Brown NH, Huynh Jr. (2005). Integrin-independent repression of cadherin transcription by talin during axis formation in Drosophila. Nat Cell Biol 7: 510-516. (Pubitemid 40637411)
5. Berrier AL, Yamada KM. (2007). Cell-matrix adhesion. J Cell Physiol 213: 565-573. (Pubitemid 350058247)
6. Blanco D, Vicent S, Elizegi E, Pino I, Fraga MF, Esteller M et al. (2004). Altered expression of adhesion molecules and epithelialmesenchymal transition in silica-induced rat lung carcinogenesis. Lab Invest 84: 999-1012. (Pubitemid 39025035)
7. Chamaon K, Kirches E, Kanakis D, Braeuninger S, Dietzmann K, Mawrin C. (2005). Regulation of the pituitary tumor transforming gene by insulin-like-growth factor-I and insulin differs between malignant and non-neoplastic astrocytes. Biochem Biophys Res Commun 331: 86-92. (Pubitemid 40545146)
8. Chen X, Sievers E, Hou Y, Park R, Tohme M, Bart R et al. (2005). Integrin alpha v beta 3-targeted imaging of lung cancer. Neoplasia 7: 271-279. (Pubitemid 40411639)
9. Cho-Rok J, Yoo J, Jang YJ, Kim S, Chu IS, Yeom YI et al. (2006). Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo. Hepatology 43: 1042-1052. (Pubitemid 43724628)
10. Christiansen JJ, Rajasekaran AK. (2006). Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66: 8319-8326. (Pubitemid 44449137)
11. Danen EH, Sonneveld P, Brakebusch C, Fassler R, Sonnenberg A. (2002). The fibronectin-binding integrins alpha5beta1 and alphavbeta3 differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis. J Cell Biol 159: 1071-1086. (Pubitemid 36055761)
12. Deng B, Yang X, Liu J, He F, Zhu Z, Zhang C. (2010). Focal adhesion kinase mediates TGF-beta1-induced renal tubular epithelial-tomesenchymal transition in vitro. Mol Cell Biochem 340: 21-29.
13. El-Naggar SM, Malik MT, Kakar SS. (2007). Small interfering RNA against PTTG: a novel therapy for ovarian cancer. Int J Oncol 31: 137-143.
14. Ezzell RM, Goldmann WH, Wang N, Parashurama N, Ingber DE. (1997). Vinculin promotes cell spreading by mechanically coupling integrins to the cytoskeleton. Exp Cell Res 231: 14-26. (Pubitemid 27187510)
15. Firrincieli D, Boissan M, Chignard N. (2010). Epithelial-mesenchymal transition in the liver. Gastroenterol Clin Biol 34: 523-528.
16. Giancotti FG, Tarone G. (2003). Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol 19: 173-206. (Pubitemid 37487347)
17. Gladson CL, Cheresh DA. (1991). Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 88: 1924-1932.
18. Gong J, Wang D, Sun L, Zborowska E, Willson JK, Brattain MG. (1997). Role of alpha 5 beta 1 integrin in determining malignant properties of colon carcinoma cells. Cell Growth Differ 8: 83-90. (Pubitemid 27030241)
19. Guillou H, Depraz-Depland A, Planus E, Vianay B, Chaussy J, Grichine A et al. (2008). Lamellipodia nucleation by filopodia depends on integrin occupancy and downstream Rac1 signaling. Exp Cell Res 314: 478-488.
20. Hamid T, Malik MT, Kakar SS. (2005). Ectopic expression of PTTG1/securin promotes tumorigenesis in human embryonic kidney cells. Mol Cancer 4: 3.
21. Hayashi I, Vuori K, Liddington RC. (2002). The focal adhesion targeting (FAT) region of focal adhesion kinase is a four-helix bundle that binds paxillin. Nat Struct Biol 9: 101-106. (Pubitemid 34132410)
22. Heaney AP, Melmed S. (1999). Pituitary tumour transforming gene: a novel factor in pituitary tumour formation. Baillieres Best Pract Res Clin Endocrinol Metab 13: 367-380. (Pubitemid 30312448)
23. Hofmann UB, Westphal JR, Waas ET, Becker JC, Ruiter DJ, van Muijen GN. (2000). Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression. J Invest Dermatol 115: 625-632.
24. Honda S, Hayashi M, Kobayashi Y, Ishikawa Y, Nakagawa K, Tsuchiya E. (2003). A role for the pituitary tumor-transforming gene in the genesis and progression of non-small cell lung carcinomas. Anticancer Res 23: 3775-3782. (Pubitemid 37474324)
25. Huber MA, Kraut N, Beug H. (2005). Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558. (Pubitemid 41267170)
26. Huveneers S, Arslan S, van de Water B, Sonnenberg A, Danen EH. (2008). Integrins uncouple Src-induced morphological and oncogenic transformation. J Biol Chem 283: 13243-13251.
27. Hynes RO. (2002). Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687. (Pubitemid 35283958)
28. Jarzynka MJ, Hu B, Hui KM, Bar-Joseph I, Gu W, Hirose T et al. (2007). ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion. Cancer Res 67: 7203-7211. (Pubitemid 47206548)
29. Kakar SS, Jennes L. (1999). Molecular cloning and characterization of the tumor transforming gene (TUTR1): a novel gene in human tumorigenesis. Cytogenet Cell Genet 84: 211-216. (Pubitemid 29294968)
30. Kakar SS, Malik MT. (2006). Suppression of lung cancer with siRNA targeting PTTG. Int J Oncol 29: 387-395.
31. Keshamouni VG, Michailidis G, Grasso CS, Anthwal S, Strahler JR, Walker A et al. (2006). Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res 5: 1143-1154. (Pubitemid 43727792)
32. Kim K, Lu Z, Hay ED. (2002). Direct evidence for a role of betacatenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int 26: 463-476. (Pubitemid 34762099)
33. Klemke RL, Leng J, Molander R, Brooks PC, Vuori K, Cheresh DA. (1998). CAS/Crk coupling serves as a 'molecular switch' for induction of cell migration. J Cell Biol 140: 961-972. (Pubitemid 28141232)
34. Kumada K, Nakamura T, Nagao K, Funabiki H, Nakagawa T, Yanagida M. (1998). Cut1 is loaded onto the spindle by binding to Cut2 and promotes anaphase spindle movement upon Cut2 proteolysis. Curr Biol 8: 633-641. (Pubitemid 28257967)
35. Lee IA, Seong C, Choe IS. (1999). Cloning and expression of human cDNA encoding human homologue of pituitary tumor transforming gene. Biochem Mol Biol Int 47: 891-897. (Pubitemid 29240508)
36. Liang H, Zhong Y, Luo Z, Huang Y, Lin H, Luo M et al. (2010). Assessment of biomarkers for clinical diagnosis of papillary thyroid carcinoma with distant metastasis. Int J Biol Markers 25: 38-45.
37. Liu G, Guibao CD, Zheng J. (2002). Structural insight into the mechanisms of targeting and signaling of focal adhesion kinase. Mol Cell Biol 22: 2751-2760. (Pubitemid 34262995)
38. Malik MT, Kakar SS. (2006). Regulation of angiogenesis and invasion by human pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2). Mol Cancer 5: 61.
39. Martin KH, Boerner SA, Parsons JT. (2002). Regulation of focal adhesion targeting and inhibitory functions of the FAK related protein FRNK using a novel estrogen receptor 'switch'. Cell Motil Cytoskeleton 51: 76-88. (Pubitemid 34183989)
40. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC. (2005). The role of focal-adhesion kinase in cancer-a new therapeutic opportunity. Nat Rev Cancer 5: 505-515. (Pubitemid 40942827)
41. Mercado-Pimentel ME, Runyan RB. (2007). Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart. Cells Tissues Organs 185: 146-156. (Pubitemid 46956855)
42. Micalizzi DS, Farabaugh SM, Ford HL. (2010). Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 15: 117-134.
43. Mizejewski GJ. (1999). Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med 222: 124-138.
44. Nakashima N, Rose DW, Xiao S, Egawa K, Martin SS, Haruta T et al. (1999). The functional role of CrkII in actin cytoskeleton organization and mitogenesis. J Biol Chem 274: 3001-3008. (Pubitemid 29075387)
45. Ning S, Tian J, Marshall DJ, Knox SJ. (2010). Anti-alphav integrin monoclonal antibody intetumumab enhances the efficacy of radiation therapy and reduces metastasis of human cancer xenografts in nude rats. Cancer Res 70: 7591-7599.
46. Nishiya N, Tachibana K, Shibanuma M, Mashimo JI, Nose K. (2001). Hic-5-reduced cell spreading on fibronectin: competitive effects between paxillin and Hic-5 through interaction with focal adhesion kinase. Mol Cell Biol 21: 5332-5345. (Pubitemid 32702439)
47. Orlando RA, Cheresh DA. (1991). Arginine-glycine-aspartic acid binding leading to molecular stabilization between integrin alpha v beta 3 and its ligand. J Biol Chem 266: 19543-19550. (Pubitemid 21908264)
48. Panguluri SK, Kakar SS. (2009). Effect of PTTG on endogenous gene expression in HEK 293 cells. BMC Genomics 10: 577.
49. Parsons JT. (2003). Focal adhesion kinase: the first ten years. J Cell Sci 116: 1409-1416. (Pubitemid 36527488)
50. Pei L, Melmed S. (1997). Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 11: 433-441. (Pubitemid 27147011)
51. Petit V, Boyer B, Lentz D, Turner CE, Thiery JP, Valles AM. (2000). Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells. J Cell Biol 148: 957-970.
52. Playford MP, Schaller MD. (2004). The interplay between Src and integrins in normal and tumor biology. Oncogene 23: 7928-7946. (Pubitemid 39468852)
53. PonnusamyMP, Lakshmanan I, Jain M, Das S, Chakraborty S, Dey P et al. (2010). MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. Oncogene 29: 5741-5754.
54. Reddig PJ, Juliano RL. (2005). Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev 24: 425-439. (Pubitemid 41569982)
55. Rolli M, Fransvea E, Pilch J, Saven A, Felding-Habermann B. (2003). Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci USA 100: 9482-9487. (Pubitemid 37033954)
56. Ross RS. (2004). Molecular and mechanical synergy: cross-talk between integrins and growth factor receptors. Cardiovasc Res 63: 381-390. (Pubitemid 38970182)
57. Ruoslahti E. (1994). Cell adhesion and tumor metastasis. Princess Takamatsu Symp 24: 99-105.
58. Ruoslahti E. (1996). RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12: 697-715. (Pubitemid 26422728)
59. Savagner P, Yamada KM, Thiery JP. (1997). The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol 137: 1403-1419. (Pubitemid 27265951)
60. Schaller MD, Otey CA, Hildebrand JD, Parsons JT. (1995). Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains. J Cell Biol 130: 1181-1187.
61. Schmalhofer O, Brabletz S, Brabletz T. (2009). E-cadherin, betacatenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 28: 151-166.
62. Seftor RE, Seftor EA, Gehlsen KR, Stetler-Stevenson WG, Brown PD, Ruoslahti E et al. (1992). Role of the alpha v beta 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci USA 89: 1557-1561.
63. Shibata Y, Haruki N, Kuwabara Y, Nishiwaki T, Kato J, Shinoda N et al. (2002). Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer. Jpn J Clin Oncol 32: 233-237. (Pubitemid 43102805)
64. Solbach C, Roller M, Fellbaum C, Nicoletti M, Kaufmann M. (2004). PTTG mRNA expression in primary breast cancer: a prognostic marker for lymph node invasion and tumor recurrence. Breast 13: 80-81. (Pubitemid 38228595)
65. Taneyhill LA, Coles EG, Bronner-Fraser M. (2007). Snail2 directly represses cadherin6B during epithelial-to-mesenchymal transitions of the neural crest. Development 134: 1481-1490. (Pubitemid 46746300)
66. Tang MH, Tan J, Cui FL. (2010). Expression of pituitary tumor transforming gene in human renal clear cell carcinoma and its significance. Nan Fang Yi Ke Da Xue Xue Bao 30: 1712-1714.
67. Thiery JP. (2003). Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-746. (Pubitemid 37487967)
68. Tsai SJ, Lin SJ, Cheng YM, Chen HM, Wing LY. (2005). Expression and functional analysis of pituitary tumor transforming gene-1 corrected in uterine leiomyomas. J Clin Endocrinol Metab 90: 3715-3723.
69. Turner CE. (2000). Paxillin and focal adhesion signalling. Nat Cell Biol 2: E231-E236.
70. Vaezi A, Bauer C, Vasioukhin V, Fuchs E. (2002). Actin cable dynamics and Rho/Rock orchestrate a polarized cytoskeletal architecture in the early steps of assembling a stratified epithelium. Dev Cell 3: 367-381.
71. Valles AM, Beuvin M, Boyer B. (2004). Activation of Rac1 by paxillin-Crk-DOCK180 signaling complex is antagonized by Rap1 in migrating NBT-II cells. J Biol Chem 279: 44490-44496. (Pubitemid 39430855)
72. Wang H, Linghu H, Wang J, Che YL, Xiang TX, Tang WX et al. (2010). The role of Crk/Dock180/Rac1 pathway in the malignant behavior of human ovarian cancer cell SKOV3. Tumour Biol 31: 59-67.
73. Wendt MK, Smith JA, Schiemann WP. (2010). Transforming growth factor-beta-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene 29: 6485-6498.
74. Westhoff MA, Serrels B, Fincham VJ, Frame MC, Carragher NO. (2004). SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling. Mol Cell Biol 24: 8113-8133. (Pubitemid 39167461)
75. Yan S, Zhou C, Lou X, Xiao Z, Zhu H, Wang Q et al. (2009). PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma. Cancer Res 69: 3283-3290.
76. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C et al. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939. (Pubitemid 38798858)
77. Yilmaz M, Christofori G. (2009). EMT, the cytoskeleton, and cancer cell invasion. Cancer Metast Rev 28: 15-33.
78. Zavadil J, Bottinger EP. (2005). TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24: 5764-5774.
79. Zhang X, Horwitz GA, Prezant TR, Valentini A, Nakashima M, Bronstein MD et al. (1999). Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol 13: 156-166. (Pubitemid 29022288)
80. Zheng DQ, Woodard AS, Fornaro M, Tallini G, Languino LR. (1999). Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway. Cancer Res 59: 1655-1664. (Pubitemid 29160140)
81. Zou H, McGarry TJ, Bernal T, Kirschner MW. (1999). Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285: 418-422.
82. Zuk A, Hay ED. (1994). Expression of beta 1 integrins changes during transformation of avian lens epithelium to mesenchyme in collagen gels. Dev Dyn 201: 378-393.